Inhibrx Biosciences annual return on equity
2023
2024
2025
Inhibrx Biosciences Return on Equity (ROE) Growth & History (INBX)
Inhibrx Biosciences's return on equity was −197.85% for fiscal 2025.
View full Inhibrx Biosciences company overviewInhibrx Biosciences annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −197.85% | −2103.77 pp |
| 2024 | 2024-12-31 | 1,905.92% | +3239.30 pp |
| 2023 | 2023-12-31 | −1,333.38% | — |
Inhibrx Biosciences quarterly return on equity
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q4 2025 | 2025-12-31 | −146.51% | −115.83 pp |
| Q3 2025 | 2025-09-30 | −66.91% | −44.85 pp |
| Q2 2025 | 2025-06-30 | −35.16% | −1448.80 pp |
| Q1 2025 | 2025-03-31 | −37.99% | — |
| Q4 2024 | 2024-12-31 | −30.68% | — |
| Q3 2024 | 2024-09-30 | −22.05% | — |
| Q2 2024 | 2024-06-30 | 1,413.64% | — |
Inhibrx Biosciences return on equity trends
Between the periods ended 2023-12-31 and 2025-12-31, Inhibrx Biosciences's return on equity increased from −1,333.38% to −197.85%, a change of +1135.53 percentage points. The latest reported quarter, Q4 2025, shows −146.51%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Inhibrx Biosciences source filings ↗